Literature DB >> 28949843

Does experience matter? Implications for community consultation for research in emergency settings.

Victoria M Scicluna1, Mohammed K Ali2, Rebecca D Pentz1,3, David W Wright4, Neal W Dickert1,2.   

Abstract

BACKGROUND: Community consultation (CC) is required for research in emergency settings using an exception from informed consent (EFIC) in the United States, but uncertainty persists regarding best CC practices. There is ongoing debate about whom to include in CC, specifically, whether to prioritize geographically defined communities or individuals with connections to the condition. Understanding the impact of personal disease experience on views of EFIC research is important for designing CC and interpreting its results.
METHODS: This study was a secondary analysis of surveys administered to 2612 participants at 12 sites in CC events conducted for ProTECT III: Progesterone for Traumatic Brain Injury, a Phase III, randomized trial conducted using EFIC. Key survey domains included personal traumatic brain injury (TBI) experience, demographic information, and acceptance of both hypothetical personal enrollment under EFIC and the use of EFIC in general in ProTECT III. Descriptive statistics and multivariable regression models were used to explore relationships between key domains.
RESULTS: TBI patients, those with family members/loved ones with TBI, and those who knew someone else with TBI were slightly more accepting of hypothetical personal enrollment under EFIC (adjusted odds ratio [OR] 1.14 [0.78-1.67], 1.54 [1.17-2.02], and 1.51 [1.19-1.92], respectively) and use of EFIC in general (adjusted OR 1.17 [0.83-1.64], 1.39 [1.08-1.77], and 1.06 [0.86-1.31], respectively) than those without this. In a subgroup analysis based on race, white participants with any disease experience had higher levels of acceptance of EFIC, as expected. However, there was numerically lower acceptance of personal and general EFIC enrollment among black participants with closer TBI connections.
CONCLUSIONS: Personal TBI experience was associated with increased acceptance of EFIC research for that condition, except among black participants. Heterogeneity of the effect of personal disease experience on EFIC views further supports inclusion of individuals with relevant disease experience in CC and highlights the importance of engaging minority participants.

Entities:  

Keywords:  bioethics; emergency medicine; empirical research; informed consent; research ethics; traumatic brain injury

Mesh:

Substances:

Year:  2017        PMID: 28949843     DOI: 10.1080/23294515.2017.1308978

Source DB:  PubMed          Journal:  AJOB Empir Bioeth        ISSN: 2329-4515


  5 in total

1.  Exploring the inclusion of under-served groups in trials methodology research: an example from ethnic minority populations' views on deferred consent.

Authors:  Timia Raven-Gregg; Victoria Shepherd
Journal:  Trials       Date:  2021-09-03       Impact factor: 2.728

Review 2.  Meeting unique requirements: Community consultation and public disclosure for research in emergency setting using exception from informed consent.

Authors:  Neal W Dickert; Kathleen Metz; Michael D Fetters; Adrianne N Haggins; Deneil K Harney; Candace D Speight; Robert Silbergleit
Journal:  Acad Emerg Med       Date:  2021-05-26       Impact factor: 5.221

3.  Patient and public involvement: Two sides of the same coin or different coins altogether?

Authors:  Matthew S McCoy; Jonathan Warsh; Leah Rand; Michael Parker; Mark Sheehan
Journal:  Bioethics       Date:  2019-04-08       Impact factor: 1.898

4.  Public Approval of Exception From Informed Consent in Emergency Clinical Trials: A Systematic Review of Community Consultation Surveys.

Authors:  William B Feldman; Spencer P Hey; Jessica M Franklin; Aaron S Kesselheim
Journal:  JAMA Netw Open       Date:  2019-07-03

5.  Patient and surrogate attitudes via an interviewer-administered survey on exception from informed consent enrollment in the Prehospital Air Medical Plasma (PAMPer) trial.

Authors:  Insiyah Campwala; Francis X Guyette; Joshua B Brown; Peter W Adams; Barbara J Early; Mark H Yazer; Matthew D Neal; Brian S Zuckerbraun; Jason L Sperry
Journal:  BMC Emerg Med       Date:  2020-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.